Company / Net Income
Praxis Precision Medicines, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$303.3M
FY2025
5-year range
-$303.3M / -$123.3M
FY2021-FY2025
Trend
-65.9%
vs FY2024
Sector context
#178 of 216
Health Care
What the data says
Praxis Precision Medicines, Inc.'s net income of -$303M is lower than 82% of companies in the Health Care sector (FY2025). Declined from -$123M to -$303M over the past 2 years.
Based on SEC 10-K filings.
-$303M in FY2025.
Declined from -$123M to -$303M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 216This company -$303.3M Sector average $454.3M
▼
-166.8% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 65.9% year-over-year.
- Ranks #178 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$303.3M | -65.9% |
| FY2024 | -$182.8M | -48.3% |
| FY2023 | -$123.3M | +42.4% |
| FY2022 | -$214.0M | -28.1% |
| FY2021 | -$167.1M | -170.2% |
| FY2020 | -$61.8M | -74.1% |
| FY2019 | -$35.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026